100
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Study of the influence of alkalizing components on matrix pellets prepared by extrusion/spheronization

, , &
Pages 204-211 | Received 11 Jun 2010, Accepted 09 Oct 2010, Published online: 10 Nov 2010

References

  • Ghebre-Sellassie I. Pharmaceutical pelletisation technology. New York: Marcel Dekker Inc; 1989.
  • Otsuka M, Gao J, Matsuda Y. Effect of amount of added water during extrusion-spheronization process on pharmaceutical properties of granules. Drug Dev Ind Pharm 1994;20:2977–2992.
  • Newton JM. Extrusion/spheronization. In: Chulia D, Deleuil M, Pourcelot Y, editors. Powder technology and pharmaceutical processes. Amsterdam: Elsevier; 1994.
  • Noche C, Barochez BH, Brossard C, Horvath S, Cuiné A. Optimising the manufacturing process for controlled release pellets. Pharm Techn Eur 1994;4:39–46.
  • Fekete R. Effect of the formulation parameters on the characteristics of pellets. Drug Dev Ind Pharm 1998;24:1073–1076.
  • Santos H, Veiga F, Pina M, Podczeck F, Sousa J. Physical properties of chitosan pellets produced by extrusion/spheronization: Influence of formulation variables. Int J Pharm 2002;246:153–169.
  • De Brabander C, Vervaet C, Remon JP. Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion. J Control Release 2003;89:235–247.
  • De Brabander C, Vervaet C, Van Bortel L, Remon JP. Bioavailability of ibuprofen from hot-melt extruded mini-matrices. Int J Pharm 2004;271:77–84.
  • Nikam AP, Bodhankar SL, Piplani P, Bansal J, Thakurdesai PA. Beta-adrenoreceptor blocking and antihypertensive activity of pp-24 a newly synthesized aryloxypropanolamie derivative. J Pharm Pharmcol 2008;60:1501–1506.
  • Niebyl JR. Teratology and drugs in pregnancy and lactation. In: Scott T, editor. Danforth’s obstetrics and gynecology. 6th ed. Philadelphia: Lipincott; 1990.
  • Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 4th ed. Baltimore: Williams and Wilkins; 1994.
  • Tabacova SA, Kimmel CA. Atenolol: Pharmacokinetic/dynamic aspects of comparative developmental toxicity. Reprod Toxicol 2002;16:1–7.
  • Reeves PR, et al. Disposition and metabolism of atenolol in animals. Xenobiotica 1978;8:305–311.
  • Fitzgerald JD. The biological and clinical effects of atenolol (Tenormin), a cardioselective-antagonist. In: Goldberg ME, editor. Pharmacological and biochemical properties of drug substances. Vol. II. Washington DC: American Pharmaceutical Association Press; 1979.
  • Thompson FD. Review of clinical pharmacology of atenolol. Proc Royal Soc Med (Suppl. 5):1977;70:5–8.
  • Wallace JW. Cellulose derivatives and natural products utilized in pharmaceutics. In: Swarbrick J, Boylan JC, editors. Encyclopedia of pharmaceutical technology. Vol. 2. New York: Marcel Dekker; 1990:319–339.
  • Iyer RM, Augsburger LL, Parikh DM. Evaluation of drug layering and coating: Effect of process mode and binder level. Drug Dev Ind Pharm 1993;19:981–998.
  • Ye Z-W, Rombout P, Remon JP, Vervaet C, Van Den Mooter G. Correlation between the permeability of metoprolol tartrate through plasticized isolated ethylcellulose/hydroxypropylmethylcellulose films and drug release from reservoir pellets. Eur J Pharm Biopharm 2007;67:485–490.
  • Fan TY, Wei SL, Yan WW, Chen DB, Li J. An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets. J Control Release 2001;77:245–251.
  • Huang J, Wigent RJ, Bentzley CM, Schwartz JB. Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery. Effect of drug loading on release kinetics. Int J Pharm 2006;319:44–54.
  • Corti G, Cirri M, Maestrelli F, Mennini N, Mura P. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-β-cyclodextrin. Eur J Pharm Biopharm 2008;68:303–309.
  • Shah RD, Kabadi M, Pope DG, Augsburger LL. Physicomechanical characterization of the extrusion-spheronization process. 2. Rheological determinants for successful extrusion and spheronisation. Pharm Res 1995;12:496–507.
  • Newton JM. Extrusion and extruders. In: Swarbrick J, Boylan JC, editors. Encyclopedia of pharmaceutical technology. New York and Basel: Marcel Dekker Inc; 2002:1220–1236.
  • Hamedelniel EI, Bajdik J, Pintye-Hódi, K. Optimization of preparation of matrix pellets containing ethylcellulose. Chem Eng Process 2010;49:120–124.
  • Nürnberg E, Surmann P, editors. Hagers Handbuch der pharmazeutischen Praxis. 5th ed. Methoden, Berlin, New York: Springer Verlag, Bd. 2; 1991. p 60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.